Page 106 - AN-2-2

Advanced Neurology Inflammatory myopathies during COVID-19

https://doi.org/10.1007/s11926-021-01023-9 29: 20–36.
15. Naveen R, Sundaram TG, Agarwal V, et al., 2021, 22. Anka AU, Tahir MI, Abubakar SD, et al., 2021,
Teleconsultation experience with the idiopathic Coronavirus disease 2019 (COVID-19): An overview of the
inflammatory myopathies: A prospective observational immunopathology, serological diagnosis and management.
cohort study during the COVID-19 pandemic. Rheumatol Scand J Immunol, 93: e12998.
Int, 41: 67–76. https://doi.org/10.1111/sji.12998
https://doi.org/10.1007/s00296-020-04737-8 23. Li YC, Bai WZ, Hashikawa T, 2020, The neuroinvasive
16. Venalis P, Lundberg IE, 2014, Immune mechanisms in potential of SARS-CoV2 may play a role in the respiratory
polymyositis and dermatomyositis and potential targets for failure of COVID-19 patients. J Med Virol, 92: 552–555.
therapy. Rheumatology (Oxford), 53: 397–405. https://doi.org/10.1002/jmv.25728
https://doi.org/10.1093/rheumatology/ket279 24. Zubair AS, McAlpine LS, Gardin T, et al., 2020,
17. Albakri AM, Subki AH, Albeity A, et al., 2022, Neuropathogenesis and neurologic manifestations of the
Dermatomyositis flare after a COVID-19 infection coronaviruses in the age of coronavirus disease 2019:
successfully treated with rituximab: A case report and A review. JAMA Neurol, 77: 1018–1027.
literature review. J Inflamm Res, 15: 6047–6053. https://doi.org/10.1001%2Fjamaneurol.2020.2065
https://doi.org/10.2147/JIR.S369477 25. Canetta C, Accordino S, Buscarini E, et al., 2020, Syncope at
18. Cheeti A, Brent LH, Panginikkod S, 2022, Autoimmune SARS-CoV-2 onset. Auton Neurosci, 229: 102734.
myopathies. In: StatPearls. Treasure Island, FL: StatPearls https://doi.org/10.1016%2Fj.autneu.2020.102734
Publishing.
26. Batchu S, Diaz MJ, Tran JT, et al., 2023, Spatial mapping
19. Amin S, Rahim F, Noor M, et al., 2022, Polymyositis: The of genes implicated in SARS-CoV-2 neuroinvasion to
comet tail after COVID-19. Cureus, 14: e26453. dorsolateral prefrontal cortex gray matter. COVID, 3: 82–89.
https://doi.org/10.7759/cureus.26453 https://doi.org/10.3390/covid3010005
20. Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G, 27. Sizemore G, Lucke-Wold B, Small C, 2022, Review of
2021 New onset of autoimmune diseases following SARS-COV-2 systemic impact: Building the case for sepsis
COVID-19 diagnosis. Cells, 10: 3592. via virus in the circulatory system. SM J Neurol Disord
https://doi.org/10.3390/cells10123592 Stroke, 6: 7.
28. Small C, Mehkri Y, Panther E, et al., 2020, Coronavirus
21. Ochani R, Asad A, Yasmin F, et al., 2021, COVID-19
pandemic: From origins to outcomes. A comprehensive disease-2019 and stroke: Pathophysiology and management.
review of viral pathogenesis, clinical manifestations, Can J Neurol Sci, 28: 1–8.
diagnostic evaluation, and management. Infez Med, https://doi.org/10.1017/cjn.2022.267

Volume 2 Issue 2 (2023) 8 https://doi.org/10.36922/an.378